Taro Pharmaceutical
TARO
$42.40
Share price
-0.19%
Change (1 day)
72.22%
Change (1 year)
Categories
Earnings for Taro Pharmaceutical (TARO)
Earnings in 2023 (TTM): $43.72 M
According to Taro Pharmaceutical's latest financial reports the company's current earnings (TTM) are $43.72 M. an increase over its 2022 earnings that were of -$15.68 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Taro Pharmaceutical from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | $43.72 M | -378.92% |
| 2022 | -$15.68 M | -96.01% |
| 2021 | -$0.4 B | -281.6% |
| 2020 | $0.21 B | -34.33% |
| 2019 | $0.32 B | 16.3% |
| 2018 | $0.28 B | -24.97% |
| 2017 | $0.37 B | -38.75% |
| 2016 | $0.61 B | -4.59% |
| 2015 | $0.64 B | 33.56% |
| 2014 | $0.48 B | 19.73% |
| 2013 | $0.40 B | 17.75% |
| 2012 | $0.34 B | 56.65% |
| 2011 | $0.21 B | 145.34% |
| 2010 | $89.32 M | 28.02% |
| 2009 | $69.77 M | |
| 2005 | $16.83 M | -3356.09% |
| 2004 | -$0.52 M | -100.69% |
| 2003 | $74.68 M | 40.23% |
| 2002 | $53.25 M | 62.5% |
| 2001 | $32.77 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | 38,713.55% | 🇺🇸 USA |
 Novartis NVS | $9.43 B | 21,483.92% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | 7,371.36% | 🇺🇸 USA |
 Merck MRK | $3.03 B | 6,840.79% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.53 B | 17,131.96% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $0.40 B | 826.20% | 🇮🇱 Israel |